TCA
WX

Taconic Capital Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Taconic Capital Advisors’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,150,000
Closed -$92.9M – 98
2015
Q3 		$92.9M Buy
2,150,000
+2,100,000
+4,200% +$88.6M 3.43% 7
2015
Q2 		$2.11M Buy
+50,000
New +$2.11M 0.06% 79

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Taconic Capital Advisors's WX Position: Q4 2015 in Review

Taconic Capital Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 2,150,000 shares — an estimated $92.9M sold.

Taconic Capital Advisors first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $92.9M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Taconic Capital Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Taconic Capital Advisors sold 2,150,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $92.9M.
  • Taconic Capital Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
  • Taconic Capital Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $92.9M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Taconic Capital Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.